Effect of angiotensin-converting enzyme inhibitors on endothelium-dependent peripheral vasodilation in patients with chronic heart failure

J Am Coll Cardiol. 1994 Nov 1;24(5):1321-7. doi: 10.1016/0735-1097(94)90115-5.

Abstract

Objectives: This study was performed to determine whether acute inhibition of angiotensin-converting enzyme restores impaired endothelium-dependent vasorelaxation in patients with chronic heart failure.

Background: Recent reports have demonstrated that endothelium-dependent vasodilation induced by cholinergic stimuli is attenuated in the peripheral vascular bed of patients with chronic heart failure.

Methods: We examined the effects of local intraarterial infusion of enalaprilat (0.6 micrograms/min per 100 ml tissue volume) on responses initiated by acetylcholine or sodium nitroprusside in the forearm vascular bed in 8 normal subjects, 12 patients with mild heart failure (New York Heart Association functional classes I and II) and 10 patients with more advanced heart failure (functional classes III and IV). Forearm blood flow was measured by means of venous occlusion plethysmography.

Results: Although enalaprilat alone did not affect basal forearm blood flow, it significantly augmented the increase in forearm blood flow induced by acetylcholine in normal subjects (p < 0.01) and in those with mild heart failure (p < 0.05). However, the effect was not found in patients with more advanced heart failure. Coinfusion of enalaprilat did not enhance sodium nitroprusside-induced vasodilation in any of the groups. To explore the mechanism of the inhibitor's effect, an additional 20 patients with mild heart failure (functional class II) were pretreated with a cyclooxygenase inhibitor, acetylsalicylic acid (n = 10) or an inhibitor of nitric oxide synthesis, NG-monomethyl-L-arginine (n = 10), followed by administration of acetylcholine with or without enalaprilat. Acetylsalicylic acid reduced the converting enzyme inhibitor's effect, whereas NG-monomethyl-L-arginine failed to block the augmentation of blood flow.

Conclusions: These results suggest that inhibition of angiotensin-converting enzyme potentiates endothelium-dependent vasodilation induced by cholinergic stimuli, presumably through modulation of prostaglandin metabolism, in the peripheral vasculature of patients with mild chronic heart failure.

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Acetylcholine
  • Arginine / analogs & derivatives
  • Arginine / pharmacology
  • Aspirin / pharmacology
  • Enalaprilat / pharmacology*
  • Endothelium, Vascular / physiology*
  • Female
  • Forearm / blood supply
  • Heart Failure / physiopathology*
  • Hemodynamics / drug effects
  • Humans
  • Infusions, Intra-Arterial
  • Male
  • Middle Aged
  • Nitric Oxide / antagonists & inhibitors
  • Nitroprusside
  • Peptidyl-Dipeptidase A / physiology
  • Plethysmography
  • Premedication
  • Vasodilation / drug effects*
  • omega-N-Methylarginine

Substances

  • Nitroprusside
  • omega-N-Methylarginine
  • Nitric Oxide
  • Arginine
  • Peptidyl-Dipeptidase A
  • Enalaprilat
  • Acetylcholine
  • Aspirin